Y. Su

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Hung-Ming Wang, R. Greil, K. Harrington, 2019, The Lancet.

Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma.

D. Pfister, H. Schöder, R. Ghossein, 2013, Thyroid : official journal of the American Thyroid Association.

Double‐Blind, Placebo‐Controlled, Randomized Trial of Granulocyte‐Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

J. Shah, M. Zelefsky, A. Vickers, 2006, Cancer journal.

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.

A. Hauschild, D. Schadendorf, J. Taube, 2022, The New England journal of medicine.

A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors.

P. LoRusso, M. Gordon, S. Wind, 2015, Future oncology.

Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.

M. Shah, Y. Janjigian, M. Capanu, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

M. Kris, C. Azzoli, N. Rosen, 2007, Cancer Chemotherapy and Pharmacology.

Immunoglobulin G4–related sclerosing disease of the paranasal sinus

Y. Su, Robert H. Lindau, Russell B. Smith, 2012, Head & neck.

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

Suzanne L Wolden, Eric Lis, J. Shah, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary intestinal‐type adenocarcinoma of the oral tongue: Case report and review of histologic origin and oncologic management

Y. Su, A. Coughlin, Rodolfo E Manosalva, 2018, Head & neck.

Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.

J. Homsi, N. Khushalani, P. Swiecicki, 2023, The Lancet. Oncology.